CUECue Biopharma, Inc.
- Market cap
- $135.55M
- as of 2026-10-23
- Latest close
- $18.66
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-01-04
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Ray SumitaChief Legal Compliance Officer | Oct 12 | Oct 14 | S | 1,844 | $28.05 | Sale −$51,724 | 116,701 | No | Form 4 |
| Meluzio Michael VincentVP, Prin. Accounting Officer | Oct 12 | Oct 14 | S | 1,144 | $28.05 | Sale −$32,089 | 47,817 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Oct 12 | Oct 14 | S | 10,000 | $27.50 | Sale −$275,000 | 695,995 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Oct 12 | Oct 14 | S | 1,087 | $28.05 | Sale −$30,490 | 694,908 | No | Form 4 |
| Garzone Pamela | Jul 9 | Aug 284/A | A | 18,900 | $0.00 | $0 | 18,900 | No | Form 4/A |
| Sarraf Pasha | Jul 9 | Aug 284/A | A | 18,400 | $0.00 | $0 | 29,195 | No | Form 4/A |
| Ray SumitaChief Legal Compliance Officer | Aug 13 | Aug 17 | M | 18,196 | $0.00 | $0 | 127,374 | No | Form 4 |
| Ray SumitaChief Legal Compliance Officer | Aug 13 | Aug 17 | S | 2,383 | $29.37 | Sale −$69,989 | 124,991 | No | Form 4 |
| Ray SumitaChief Legal Compliance Officer | Aug 13 | Aug 17 | S | 6,442 | $30.35 | Sale −$195,515 | 118,549 | No | Form 4 |
| Ray SumitaChief Legal Compliance Officer | Aug 13 | Aug 17 | S | 4 | $31.13 | Sale −$125 | 118,545 | No | Form 4 |
| Ray SumitaChief Legal Compliance Officer | Aug 13 | Aug 17 | M · derivative | 18,196 | $0.00 | $0 | 36,393 | No | Form 4 |
| Meluzio Michael VincentVP, Prin. Accounting Officer | Aug 13 | Aug 17 | M | 13,647 | $0.00 | $0 | 54,589 | No | Form 4 |
| Meluzio Michael VincentVP, Prin. Accounting Officer | Aug 13 | Aug 17 | S | 1,519 | $29.37 | Sale −$44,613 | 53,070 | No | Form 4 |
| Meluzio Michael VincentVP, Prin. Accounting Officer | Aug 13 | Aug 17 | S | 4,106 | $30.35 | Sale −$124,617 | 48,964 | No | Form 4 |
| Meluzio Michael VincentVP, Prin. Accounting Officer | Aug 13 | Aug 17 | S | 3 | $31.13 | Sale −$93 | 48,961 | No | Form 4 |
| Meluzio Michael VincentVP, Prin. Accounting Officer | Aug 13 | Aug 17 | M · derivative | 13,647 | $0.00 | $0 | 27,295 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Aug 13 | Aug 14 | S | 5,423 | $27.19 | Sale −$147,451 | 718,830 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Aug 13 | Aug 14 | S | 2,375 | $28.11 | Sale −$66,761 | 716,455 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Aug 13 | Aug 14 | S | 10,460 | $29.48 | Sale −$308,361 | 705,995 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Aug 12 | Aug 14 | M | 109,179 | $0.00 | $0 | 764,253 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Aug 12 | Aug 14 | S | 34,225 | $26.99 | Sale −$923,733 | 730,028 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Aug 12 | Aug 14 | S | 5,775 | $27.75 | Sale −$160,256 | 724,253 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Aug 12 | Aug 14 | M · derivative | 109,179 | $0.00 | $0 | 218,358 | No | Form 4 |
| Ahlers James MChief Financial Officer | Jul 30 | Aug 3 | A | 25,500 | $0.00 | $0 | 25,500 | No | Form 4 |
| Ahlers James MChief Financial Officer | Jul 30 | Aug 3 | A · derivative | 51,000 | $30.40 | $1,550,400 | 51,000 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Jun 1 | Jul 304/A | A · derivative | 90,906 | $11.00 | $999,966 | 90,906 | No | Form 4/A |
| Lin Shao-LeeChief Executive Officer | Jun 1 | Jul 304/A | A · derivative | 45,453 | $11.00 | $499,983 | 45,453 | No | Form 4/A |
| Borie Dominique ChristianChief Medical Officer | Jul 13 | Jul 15 | A | 31,500 | $0.00 | $0 | 31,500 | No | Form 4 |
| Borie Dominique ChristianChief Medical Officer | Jul 13 | Jul 15 | A · derivative | 63,000 | $30.92 | $1,947,960 | 63,000 | No | Form 4 |
| Ray SumitaChief Legal Compliance Officer | Jul 9 | Jul 10 | A | 54,589 | $0.00 | $0 | 109,178 | No | Form 4 |
| Ray SumitaChief Legal Compliance Officer | Jul 9 | Jul 10 | A · derivative | 54,589 | $0.00 | $0 | 54,589 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Jul 9 | Jul 10 | A | 327,537 | $0.00 | $0 | 655,074 | No | Form 4 |
| Lin Shao-LeeChief Executive Officer | Jul 9 | Jul 10 | A · derivative | 327,537 | $0.00 | $0 | 327,537 | No | Form 4 |
| Camardo Daniel A. | Jul 9 | Jul 10 | A | 21,800 | $0.00 | $0 | 21,800 | No | Form 4 |
| Meehan Viola Mong | Jul 9 | Jul 10 | A | 21,800 | $0.00 | $0 | 21,800 | No | Form 4 |
| Meluzio Michael VincentVP, Prin. Accounting Officer | Jul 9 | Jul 10 | A | 40,942 | $0.00 | $0 | 40,942 | No | Form 4 |
| Meluzio Michael VincentVP, Prin. Accounting Officer | Jul 9 | Jul 10 | A · derivative | 40,942 | $0.00 | $0 | 40,942 | No | Form 4 |
| Camardo Daniel A. | May 30 | Jun 8 | A · derivative | 1,626 | $21.90 | $35,609 | 1,626 | No | Form 4 |
| Meehan Viola Mong | May 30 | Jun 2 | A · derivative | 1,626 | $21.90 | $35,609 | 1,626 | No | Form 4 |
| Lin Shao-LeeCHIEF EXECUTIVE OFFICER | May 3 | May 7 | A | 327,537 | $0.00 | $0 | 327,537 | No | Form 4 |
| Lin Shao-LeeCHIEF EXECUTIVE OFFICER | May 3 | May 7 | A · derivative | 655,074 | $30.42 | $19,927,351 | 655,074 | No | Form 4 |
| Baker Daniel G.CHIEF DEVELOPMENT OFFICER | Apr 9 | Apr 10 | A · derivative | 100,000 | $0.29 | $29,000 | 100,000 | No | Form 4 |
| Warren LucindaCHIEF BUSINESS OFFICER | Apr 9 | Apr 10 | A · derivative | 250,000 | $0.29 | $72,500 | 250,000 | No | Form 4 |
| Sandercock ColinSVP, GENERAL COUNSEL | Apr 9 | Apr 10 | A · derivative | 200,000 | $0.29 | $58,000 | 200,000 | No | Form 4 |
| Sarraf Pasha | Jan 2 | Jan 6 | A · derivative | 24,400 | $0.34 | $8,296 | 24,400 | No | Form 4 |
| Verheyen Patrick | Jan 2 | Jan 6 | A · derivative | 24,400 | $0.34 | $8,296 | 24,400 | No | Form 4 |
| Garzone Pamela | Jan 2 | Jan 6 | A · derivative | 24,400 | $0.34 | $8,296 | 24,400 | No | Form 4 |
| Morich Frank | Jan 2 | Jan 6 | A · derivative | 24,400 | $0.34 | $8,296 | 24,400 | No | Form 4 |
| Broadfoot Jill Marie | Jan 2 | Jan 6 | A · derivative | 24,400 | $0.34 | $8,296 | 24,400 | No | Form 4 |
| Kiener Peter A | Jan 2 | Jan 6 | A · derivative | 24,400 | $0.34 | $8,296 | 24,400 | No | Form 4 |
| Sarraf Pasha | Dec 30, 2025 | Jan 2 | P | 4,229 | $0.31 | Purchase +$1,311 | 4,229 | No | Form 4 |
| Sarraf Pasha | Dec 30, 2025 | Jan 2 | P | 77,148 | $0.30 | Purchase +$23,144 | 81,377 | No | Form 4 |
| Sarraf Pasha | Dec 30, 2025 | Jan 2 | P | 86,947 | $0.32 | Purchase +$27,823 | 168,324 | No | Form 4 |
| Sarraf Pasha | Dec 30, 2025 | Jan 2 | P | 78,116 | $0.31 | Purchase +$24,216 | 246,440 | No | Form 4 |
| Sarraf Pasha | Dec 30, 2025 | Jan 2 | P | 77,417 | $0.30 | Purchase +$23,225 | 323,857 | No | Form 4 |
| Sandercock ColinSVP, GENERAL COUNSEL | Dec 3, 2025 | Dec 5, 2025 | A · derivative | 70,000 | $0.70 | $49,000 | 70,000 | No | Form 4 |
| Sandercock ColinSVP, GENERAL COUNSEL | Sep 26, 2025 | Dec 5, 2025 | A · derivative | 30,000 | $0.70 | $21,000 | 30,000 | No | Form 4 |
| Baker Daniel G.CHIEF DEVELOPMENT OFFICER | Sep 29, 2025 | Nov 25, 2025 | A · derivative | 50,000 | $0.72 | $36,000 | 50,000 | No | Form 4 |
| Warren LucindaCHIEF BUSINESS OFFICER | Sep 29, 2025 | Nov 25, 2025 | A · derivative | 125,000 | $0.72 | $90,000 | 125,000 | No | Form 4 |
| Azam UsmanCHIEF EXECUTIVE OFFICER | Sep 29, 2025 | Oct 2, 2025 | A · derivative | 1,875,000 | $0.72 | $1,350,000 | 1,875,000 | No | Form 4 |
| Broadfoot Jill Marie | Jun 4, 2025 | Jun 6, 2025 | A · derivative | 48,800 | $0.62 | $30,256 | 48,800 | No | Form 4 |
| Levisetti MatteoChief Medical Officer | Mar 21, 2025 | Mar 25, 2025 | A · derivative | 250,000 | $0.99 | $247,500 | 250,000 | No | Form 4 |
| Warren LucindaCHIEF BUSINESS OFFICER | Mar 21, 2025 | Mar 25, 2025 | A · derivative | 250,000 | $0.99 | $247,500 | 250,000 | No | Form 4 |
| Sandercock ColinSVP, GENERAL COUNSEL | Mar 21, 2025 | Mar 25, 2025 | A · derivative | 200,000 | $0.99 | $198,000 | 200,000 | No | Form 4 |
| Baker Daniel G.CHIEF DEVELOPMENT OFFICER | Mar 21, 2025 | Mar 25, 2025 | A · derivative | 100,000 | $0.99 | $99,000 | 100,000 | No | Form 4 |
| Passeri Daniel RCHIEF EXECUTIVE OFFICER | Mar 21, 2025 | Mar 25, 2025 | A · derivative | 450,000 | $0.99 | $445,500 | 450,000 | No | Form 4 |
| Millar Kerri-AnnCHIEF FINANCIAL OFFICER | Mar 21, 2025 | Mar 25, 2025 | A · derivative | 200,000 | $0.99 | $198,000 | 200,000 | No | Form 4 |
| Sarraf Pasha | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 48,800 | $1.03 | $50,264 | 48,800 | No | Form 4 |
| Garzone Pamela | Jan 2, 2025 | Jan 3, 2025 | A · derivative | 24,400 | $1.09 | $26,596 | 24,400 | No | Form 4 |
| Verheyen Patrick | Jan 2, 2025 | Jan 3, 2025 | A · derivative | 24,400 | $1.09 | $26,596 | 24,400 | No | Form 4 |
| Kiener Peter A | Jan 2, 2025 | Jan 3, 2025 | A · derivative | 24,400 | $1.09 | $26,596 | 24,400 | No | Form 4 |
| Driscoll Frederick W | Jan 2, 2025 | Jan 3, 2025 | A · derivative | 24,400 | $1.09 | $26,596 | 24,400 | No | Form 4 |
| Morich Frank | Jan 2, 2025 | Jan 3, 2025 | A · derivative | 24,400 | $1.09 | $26,596 | 24,400 | No | Form 4 |
| Passeri Daniel RCHIEF EXECUTIVE OFFICER | Dec 16, 2024 | Dec 18, 2024 | P | 30,000 | $1.03 | Purchase +$30,900 | 164,578 | No | Form 4 |
| Baker Daniel G.CHIEF DEVELOPMENT OFFICER | Nov 25, 2024 | Nov 29, 2024 | A · derivative | 200,000 | $1.06 | $212,000 | 200,000 | No | Form 4 |
| Warren LucindaCHIEF BUSINESS OFFICER | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 350,000 | $0.66 | $231,000 | 350,000 | No | Form 4 |
| Millar Kerri-AnnCHIEF FINANCIAL OFFICER | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 60,000 | $1.65 | $99,000 | 60,000 | No | Form 4 |
| Sandercock ColinSVP, GENERAL COUNSEL | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 60,000 | $1.65 | $99,000 | 60,000 | No | Form 4 |
| Fox Michael J | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 48,800 | $1.65 | $80,520 | 48,800 | No | Form 4 |
| Suri AnishPRESIDENT AND CSO | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 150,000 | $1.65 | $247,500 | 150,000 | No | Form 4 |
| Levisetti MatteoChief Medical Officer | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 125,000 | $1.65 | $206,250 | 125,000 | No | Form 4 |
| Levisetti MatteoChief Medical Officer | Mar 6, 2024 | Mar 8, 2024 | A · derivative | 260,000 | $1.94 | $504,400 | 260,000 | No | Form 4 |
| Passeri Daniel RCHIEF EXECUTIVE OFFICER | Mar 6, 2024 | Mar 8, 2024 | A · derivative | 400,000 | $1.94 | $776,000 | 400,000 | No | Form 4 |
| Suri AnishPRESIDENT AND CSO | Mar 6, 2024 | Mar 8, 2024 | A · derivative | 300,000 | $1.94 | $582,000 | 300,000 | No | Form 4 |
| Millar Kerri-AnnCHIEF FINANCIAL OFFICER | Mar 6, 2024 | Mar 8, 2024 | A · derivative | 250,000 | $1.94 | $485,000 | 250,000 | No | Form 4 |
| Sandercock ColinSVP, GENERAL COUNSEL | Mar 6, 2024 | Mar 8, 2024 | A · derivative | 175,000 | $1.94 | $339,500 | 175,000 | No | Form 4 |
| Levisetti MatteoChief Medical Officer | Feb 20, 2024 | Feb 22, 2024 | A · derivative | 25,000 | $3.36 | $84,000 | 25,000 | No | Form 4 |
| Morich Frank | Jan 2, 2024 | Jan 4, 2024 | A · derivative | 24,400 | $2.78 | $67,832 | 24,400 | No | Form 4 |
| Verheyen Patrick | Jan 2, 2024 | Jan 4, 2024 | A · derivative | 24,400 | $2.78 | $67,832 | 24,400 | No | Form 4 |
| Driscoll Frederick W | Jan 2, 2024 | Jan 4, 2024 | A · derivative | 24,400 | $2.78 | $67,832 | 24,400 | No | Form 4 |
| Kiener Peter A | Jan 2, 2024 | Jan 4, 2024 | A · derivative | 24,400 | $2.78 | $67,832 | 24,400 | No | Form 4 |
| Garzone Pamela | Jan 2, 2024 | Jan 4, 2024 | A · derivative | 24,400 | $2.78 | $67,832 | 24,400 | No | Form 4 |